Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome

NCT01373333 · clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Cleveland Clinic